PIN5 COST-EFFECTIVENESS OF DROTRECOGIN ALFA (ACTIVATED) FOR THE TREATMENT OF SEVERE SEPSIS-A CROSS-NATIONAL COMPARISON OF THREE EUROPEAN COUNTRIES
Nov 1, 2002, 00:00 AM
10.1016/S1098-3015(10)61483-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)61483-0/fulltext
Section Title :
Section Order :
292
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61483-0&doi=10.1016/S1098-3015(10)61483-0